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Abstract
Background: The extent to which partnership synergy is created within quality improvement programmes in the
Netherlands is unknown. In this article, we describe the psychometric testing of the Partnership Self-Assessment
Tool (PSAT) among professionals in twenty-two disease-management partnerships participating in quality
improvement projects focused on chronic care in the Netherlands. Our objectives are to validate the PSAT in the
Netherlands and to reduce the number of items of the original PSAT while maintaining validity and reliability.
Methods: The Dutch version of the PSAT was tested in twenty-two disease-management partnerships with 218
professionals. We tested the instrument by means of structural equation modelling, and examined its validity and
reliability.
Results: After eliminating 14 items, the confirmatory factor analyses revealed good indices of fit with the resulting
15-item PSAT-Short version (PSAT-S). Internal consistency as represented by Cronbach’s alpha ranged from
acceptable (0.75) for the ‘efficiency’ subscale to excellent for the ‘leadership’ subscale (0.87). Convergent validity
was provided with high correlations of the partnership dimensions and partnership synergy (ranged from 0.512 to
0.609) and high correlations with chronic illness care (ranged from 0.447 to 0.329).
Conclusion: The psychometric properties and convergent validity of the PSAT-S were satisfactory rendering it a
valid and reliable instrument for assessing partnership synergy and its dimensions of partnership functioning.
Keywords: chronic care, measurement, quality, chronic illness, health care, partnership synergy, isease management
Background
The prevalence of individuals with chronic illness is
growing fast because of the rapid aging of the
population and the greater longevity of individuals. The
multiple and often complex needs of populations
affected by the epidemic of chronic illnesses requires
approaches that include collaboration among health care
professionals of various organizations and extend
beyond traditional acute episodic health care and the
services of any single organization [1-5]. Partnerships
are increasingly used to enhance health service delivery
in response to this explosion in chronic disease
prevalence. While interprofessional health partnerships
are internationally acknowledged as integral for compre-
hensive chronic illness care, the evidence for effective-
ness of such partnerships is lacking [6,7]. Partnership
collaboration requires relationships, procedures, and
structures that are quite different from the ways many
people and organizations have worked in the past and
research indicates that these partnerships are also gener-
ating a good deal of frustration [8]. In addition, building
effective partnerships is time consuming, resource inten-
sive, and often very difficult [9-12]. A number of special
challenges are involved in the management of interpro-
fessional health partnerships [12,13]. One of the main
critical tasks of partnership management is to enhance
the capacity of partnerships to achieve high levels of
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synergy. Partnership’s ability to create synergy resulting
in the redesign of patient care is an essential factor for
successful disease-management [7,8]. Synergy is the
degree to which the partnership combines the comple-
mentary strengths, perspectives, values and resources of
all partners in the search for better solutions [14: p. 5]
and is generally regarded as the product of a partnership
[15]. The synergy that a partnership can achieve is more
than simply an exchange of resources among its part-
ners. Theoretically, when partners effectively merge
their perspectives, knowledge, and skills to create
synergy, they create something new and valuable: a
whole that is greater than the sum of its parts. Lasker
and colleagues [8] developed a framework that supports
the people responsible for managing partnerships in
realizing high levels of synergy. The Partnership Self-
Assessment Tool (PSAT) was developed based on this
framework by public health specialists for practical use
by groups working to promote health and well-being in
their communities [7]. It measures partnership synergy
and other related dimensions of the partnership process
[16]. Establishment of construct validity during develop-
ment of the PSAT items was rigorous [7,9]. In addition,
it included data from qualitative interviews with mem-
bers of community health promotion partnerships, an
extensive review of relevant literature and measures, as
well as input from a panel of experts. Furthermore, the
PSAT was tested in 63 health-related partnerships in
operation at least 18 months in urban, suburban or
rural areas in the US [7]. A recent study conducted by
Butt and colleagues [17] showed that the PSAT is a
valid partnership process measurement tool.
The PSAT has not been validated in the Netherlands
to date. In this article, we describe the psychometric
testing of the PSAT among professionals in twenty-two
disease-management partnerships participating in quality
improvement projects focused on chronic care in the
Netherlands. Our objectives are to validate the PSAT in
the Netherlands and to reduce the number of items of
the original PSAT while maintaining validity and
reliability.
Methods
Disease-management partnerships
The study is in the context of a national programme on
“disease management of chronic diseases” carried out by
ZonMw (Netherlands Organisation for Health Research
and Development) and commissioned by the Dutch
Ministry of Health. The study was approved by the
ethics committee of the Erasmus University Medical
Centre of Rotterdam (September 2009).
This study is focused on the evaluation of the imple-
mentation of twenty-two disease-management partner-
ships to enhance knowledge on disease-management
experiments in chronic disease care, and stimulate
implementation of knowledge and insights of successful
programs. These disease-management partnerships are
located in various Dutch regions and consist of a variety
of collaborations between organizations and/or profes-
sionals, e.g. collaborations between general practices and
hospitals, primary care collaborations (including phy-
siotherapists and dieticians) or primary and community
settings. A questionnaire was sent to all 393 profes-
sionals participating within the 22 disease-management
partnership (consisting of 153 organizations). Either a
package of questionnaires was sent to the contact per-
son of each participating organization (which were dis-
tributed to potential respondents through their mail
boxes or delivered personally at team meetings) or ques-
tionnaires were sent directly to the potential respon-
dents. Two weeks later the same procedure was used to
send a reminder to non-respondents. A total of 218
respondents filled in the questionnaire (55% response
rate; range 35-100%).
The disease-management partnerships are targeted
at different patient populations; including cardiovascu-
lar diseases (9 disease-management partnerships),
chronic obstructive pulmonary disease (COPD) (5),
diabetes (3), heart failure (1), stroke (1), depression
(1), psychotic diseases (1) and eating disorders (1).
The intervention concerns the implementation of dis-
ease-management partnerships aiming to improve
quality of chronic care based on the Chronic Care
Models (CCM). Each disease-management partnership
consists of a combination of patient-related, profes-
sional-directed and organizational interventions. The
exact programme components for each region may
vary. The core of a DMP is described below; for
detailed programme information, see our study proto-
col [18].
Patient-related interventions
All 22 disease-management partnerships implemented
self-care interventions e.g. patient education on lifestyle,
regulatory skills, and proactive coping.
Professional-directed interventions
Care standards, guidelines, and protocols are essential
parts of the 22 disease-management partnerships. They
are integrated through timely reminders, feedback, and
other methods that increase their visibility at the time
that clinical decisions are made. The disease-manage-
ment partnerships are built on these (multidisciplinary)
guidelines. The implementation strategies for profes-
sional interventions may, however, vary. All disease-
management partnerships provide training for their
professionals and implementation of these guideline is
supported in almost all disease-management partner-
ships by ICT tools such as integrated information
systems.
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Organisational interventions
Many forms of organisational changes are applied in the
22 disease-management partnerships e.g. new collabora-
tions of care providers, allocating tasks differently, trans-
ferring information and scheduling appointments more
effectively, case management, using new types of health
professionals, redefining professionals’ roles and redistri-
buting their tasks, planned interaction between profes-
sionals, and regular follow-up meetings by the care
team.
Measures
The PSAT was used to measure partnership synergy
and dimensions of partnership functioning [7,8]. This
instrument contains partnership synergy (nine items
e.g. by working together, how well are these partners
able to identify new and creative ways to solve pro-
blems) and four dimensions of partnership functioning:
leadership (11 items e.g. fostering respect, trust, inclu-
siveness, and openness in the partnership), efficiency
(three items e.g. how well your partnership uses the
partners’ financial resources), administration and man-
agement (nine items e.g. evaluating the progress and
impact of the partnership), and resources (six items
e.g. data and information: statistical data, information
about community perceptions, values, resources, and
politics). Responses to all items are structured by a
five-point Likert scale.
Partnership synergy and dimensions of partnership
functioning scores were derived by calculating the mean
of responses within each section. The partnership
synergy score reflects the extent to which the partici-
pants in the disease-management partnership are
accomplishing more together than they can on their
own [7].
Since the disease-management partnerships aim to
improve quality of chronic care based on the CCM, we
tested convergent validity with the Assessment of
Chronic Illness Care (ACIC). The ACIC consists of 34
items covering the seven areas of the CCM: health care
organization (6 items); community linkages (3); self-
management support (4); delivery system design (6);
decision support (4); clinical information systems (5).
The ACIC also covers integrating the six components,
such as linking patients’ self-management goals to infor-
mation systems (6 items) [19]. Subscale scores for the
seven sections of the ACIC were derived by calculating
the mean of responses within each section, and overall
scores were derived by calculating the mean of all
subscale scores. We used overall scores to assess the
effectiveness of disease-management partnership in deli-
vering chronic-illness care. The highest possible score
(11) for any individual item, subscale, or overall score
was taken to indicate optimal chronic-illness care
delivery, and the lowest score (0) was considered to
correspond with limited chronic illness care delivery.
Analyses
The analyses included the following six steps.
1. The sample characteristics were analysed using
descriptive statistics.
2. We data-screened the items by examining number
of missing, number of ‘don’t know’ answers, mean
and standard deviation of each item.
3. To verify the factor structure of the questionnaire
and to test whether the relationship between
observed variables and their underlying latent
constructs exists, confirmatory factor analysis was
executed using the LISREL program [20]. In line
with the theoretical assumptions of the measurement
model, no correlation errors either within or across
sets of items were allowed in the model.
4. Item reduction analysis was performed to develop
a short version of the questionnaire that can be used
in case the original version is considered to be too
long. Items were removed from the original pool fol-
lowing several criteria: 1) Items were excluded one
by one, first by eliminating items with factor load-
ings below .40 and second by following the modifi-
cation indices, 2) eliminating items was stopped
when reliability (Cronbach’s alpha) of each subscale
drops below .70 and 3) there should be as few items
as possible with a minimum of three, without loss of
content and psychometric quality. Listwise deletion
of cases with missing data on these 29 items resulted
in N = 68. Imputation was done by replacing miss-
ing values by the mean of each disease-management
partnership as scored by the other professionals of
the same disease-management partnership, resulting
in N = 218 which was the total sample. To test the
measurement models four indices of model fit were
used. The cut-off criteria for these four indices were
those proposed by Hu and Bentler [21]. First, the
overall test of goodness-of-fit assesses the discre-
pancy between the model implied and the sample
covariance matrix by means of a normal-theory
weighted least squares test. A plausible model has
low, preferably non-significant c2 values. However,
Chi-square is overly sensitive when the sample size
is large (anything over 200) [22], leading to difficulty
in obtaining the desired non-significant level [23].
Secondly, the Root Means Square Error of Approxi-
mation (RMSEA) reflects the estimation error
divided by the degrees of freedom as a penalty func-
tion. Values on RMSEA below cut-off value 0.06
indicate small differences between the estimated and
observed model. Thirdly, we used the Standardized
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Root Means square Residual (SRMR), which is a
scale invariant index for global fit that ranges
between 0 and 1. Values on SRMR lower than cut-
off value 0.08 indicate a good fit. As a fourth index
of model fit the Incremental Fit Index (IFI) was cal-
culated. This index compares the independence
model (i.e. observed variables are unrelated) to the
estimated model. Preferably, values on IFI should be
larger than cut-off value 0.95.
5. Internal consistency of the subscales was assessed
by calculating Cronbach’s alphas, inter-item correla-
tions within each subscale and correlations between
subscales.
6. We then investigated convergent validity of the
instrument. Validity reflects the degree to which a
scale measures what it is intended to measure. We
evaluated convergent validity by analyzing the
associations between the dimensions of partnership
(original instrument and short version) with partner-
ship synergy and the ACIC.
Results
Sample characteristics
The response rate of the professionals was 55% (218/
393). The majority of the professionals that filled in the
baseline questionnaire were female (66.2%). Mean age
was 47.2 years (sd 9.47) ranging from 25 to 65. Table 1
lists descriptive characteristics of the sample of profes-
sionals. The majority of the professionals (75.1%) had
been working for more than 3 years within the organisa-
tion. Furthermore, 144 (67.6%) professionals worked
more than 29 hours per week. Disease-management
partnerships mainly consisted of general practitioners
(34.9%) and practice nurses (25.7%). Other professionals
participating in the disease-management partnership are
paramedical professionals (11.9%) and medical
specialists (2.8%).
Datascreening
All items were screened for univariate and bivariate
normality, and to detect outliers. Data screening infor-
mation was taking into account in the stepwise proce-
dure of the item reduction analysis. In general,
percentages missings and ‘don’t know’ answers were
below 10%, except for item 8 and 9 of the leadership
subscale and all of the items for administration and
management subscale (see Table 2). Especially, the
items within the administration and management sub-
scales had relatively high percentages of ‘don’t know’
answers.
Confirmatory Factor analysis with 29 items
All items had factor loadings above 0.60 on the intended
factor except for item 16 (0.56), item 18 (0.51) and item 29
(0.58) (see Table 2 last column). The indices of model fit
also showed that the model fit was sufficient (see Table 3
model 1). The significant Normal Theory Weighted Least
Square c2 statistic is not surprising given its sensitivity to
sample size; it was 1627.616. The RMSEA was below cut-
off value and acceptable. IFI value was 0.99 and well above
cut-off value of .95 and SRMR was well below cut-off
value of 0.08. All indices indicated that the model was
acceptable, but left room for shortening.
Item reduction analysis
Following the factor loadings, modification indices and
checking the internal consistency of each subscale, the
stepwise procedure resulted in elimination of items in
the following order: 27, 16, 18, 4, 20, 5, 8, 19, 21, 7, 6, 9,
10 en 28. The final short version consisted of 15 items
with three or four items for each subscale. Item reduc-
tion could be done without loss of model fit. The overall
fit of this final model was comparable with the model fit
of the full version (Table 3 model 2). Due to a decrease
in the number of estimated parameters, the Normal
Theory Weighted Least Square c2 significantly decreased
to 432.634, RMSEA was around cut-off and still accepta-
ble. The value of IFI remained 0.99 indicating that the
specified relations between variables are well supported
by the data. The SRMR index decreased to 0.0638,
which is still below the cut-off point of 0.08 and indi-
cates that the global fit of the overall model is good.
The final short model on imputed data resulted in
comparable factor loadings.
Rerun of the full model and item reduction analysis
on the non-imputed dataset with N = 68 resulted in
good fit indices and exactly the same order of items that
were eliminated.
Internal consistency and inter-correlations
Internal consistency as represented by Cronbach’s alpha
ranged from acceptable for the ‘efficiency’ subscale to
Table 1 Sample characteristics professionals (n = 218)
N Percentage
Gender - female 139 66.2%
- male 71 33.8%
Working past - more than 3 years 160 75.1%
Working hours per
week
- more than 29 hours 144 67.6%
Occupation - General Practitioner 76 34.9%
- practice nurses 56 25.7%
- policy and management 28 12.8%
- para-/perimedical
professionals
26 11.9%
- medical/social specialists 6 2.8%
- others 26 11.9%
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excellent for the ‘leadership’ subscale (Table 4). Also the
correlations between the full original subscales and
short subscales are good ranging from .92 to 1.00,
indicating acceptable coverage of the original sub
dimensions. The four subscales were significantly and
positively correlated, indicating conceptually related
subscales.
Convergent validity
Data on convergent validity of the original PSAT are
presented in Table 5. To estimate convergent validity of
the instrument we looked at correlations between part-
nership functioning and the areas that are known to be
related to synergy: (1) effectiveness of the partnership’s
leadership; (2) efficiency of the partnership; (3) effective-
ness of the partnership’s administration and manage-
ment; and (4) sufficiency of the partnership’s resources.
Results show that all dimensions of partnership synergy
are positively related to synergy (all p ≤ 0.001). We
investigated disease-management partnerships and
expected that higher levels of partnership synergy would
be related to higher levels of chronic illness care delivery
[23]. The ACIC measures chronic illness care [19],
therefore, we additionally analyzed relations between
partnership dimensions with the ACIC to verify conver-
gent validity. The results show that all dimensions of
Table 2 Item characteristics and factor loadings of the first full model
Item Valid N missing don’t know mean sd l
Leadership
1. Taking responsibility for the partnership 199 10 (4.6%) 9 (4.1%) 2.97 .78 .78
2. Inspiring or motivating people involved in the partnership 199 11 (5.0%) 8 (3.7%) 2.81 .82 .82
3. Empowering people involved in the partnership 200 10 (4.6%) 8 (3.7% 2.80 .76 .86
4. Communicating the vision of the partnership 193 12 (5.5%) 13 (6.0%) 2.75 .78 .67
5. Working to develop a common language within the partnership 191 11 (5.0%) 16 (7.3%) 2.61 .78 .72
6. Fostering respect, trust, inclusiveness, and openness in the partnership 197 10 (4.6%) 11 (5.0%) 2.92 .90 .81
7. Creating an environment where differences of opinion can be voiced 197 10 (4.6%) 11 (5.0%) 2.93 .83 .78
8. Resolving conflict among partners 175 10 (4.6%) 33 (15.1%) 2.68 .80 .74
9. Combining the perspectives, resources, and skills of partners 186 10 (4.6%) 22 (10.1%) 2.77 .73 .84
10. Helping the partnership be creative and look at things differently 192 11 (5.0%) 15 (6.9%) 2.67 .84 .83
11. Recruiting diverse people and organizations into the partnership 192 10 (4.6%) 16 (7.3%) 2.81 .82 .83
Efficiency
12. How well your partnership uses the partners’ financial resources. 179 39 (17.9%) n.a. 2.64 .88 .71
13. How well your partnership uses the partners’ in-kind resources 191 27 (12.4%) n.a. 2.82 .88 .84
14. How well your partnership uses the partners’ time. 195 23 (10.6%) n.a. 2.50 .80 .72
Administration and Management
15. Coordinating communication among partners 186 12 (5.5%) 20 (9.2%) 2.63 .69 .76
16. Coordinating communication with people and organizations outside the partnership 158 16 (7.3%) 44 (20.2%) 2.36 .65 .56
17. Organizing partnership activities, including meetings and projects 188 14 (6.4%) 16 (7.3%) 2.85 .73 .81
18. Applying for and managing grants and funds 142 14 (6.4%) 62 (28.4%) 2.80 .88 .51
19. Preparing materials that inform partners and help them make timely decisions 172 14 (6.4%) 32 (14.7%) 2.53 .79 .78
20. Performing secretarial duties 162 14 (6.4%) 42 (19.3%) 2.73 .83 .69
21. Providing orientation to new partners as they join the partnership 137 16 (7.3%) 65 (29.8%) 2.63 .77 .78
22. Evaluating the progress and impact of the partnership 170 14 (6.4%) 34 (15.6%) 2.59 .79 .77
23. Minimizing the barriers to participation in the partnership’s meetings and activities 171 14 (6.4%) 33 (15.1%) 2.53 .83 .77
Non financial resources
24. Skills and expertise 174 13 (6.0%) 0 2.44 .62 .86
25. Data and information 167 16 (7.3%) 0 2.31 .68 .82
26. Connections to target populations 165 17 (7.8%) 0 2.35 .77 .80
27. Connections to political decision-makers, government agencies, other organizations/groups 142 13 (6.0%) 0 2.09 .78 .51
28. Legitimacy and credibility 173 13 (6.0%) 0 2.59 .58 .80
29. Influence and ability to bring people together for meetings and activities 185 13 (6.0%) 0 2.34 .64 .88
Notes; items in bold are included in the short version; l = factor loadings on the intended factor.
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partnership are positively related to chronic illness care
(all p ≤ 0.001). These values indicated convergent valid-
ity. The relative weights and significance levels of the
PSAT-S are similar to the original PSAT (Table 5).
Again, all partnership dimensions are positively related
to partnership synergy and chronic illness care (all at
p ≤ 0.001). Results showed a strong relationship between
disease-management partnership dimensions, synergy
and effectiveness in chronic-illness care delivery. The
advantages achieved by partnerships with high levels of
synergy are likely to enhance partnership effectiveness
in chronic care delivery.
Discussion
This study aimed to validate the PSAT in various dis-
ease-management partnerships. Our results showed that
the PSAT is a valid and reliable instrument to measure
partnership synergy and its dimensions. The advantages
achieved by partnerships with high levels of synergy are
likely to enhance partnership effectiveness in prevention
and health promotion that have been identified by other
investigators [24]. The PSAT scores assess partnership’s
strengths and weaknesses in areas that are known to be
related to synergy: (1) effectiveness of the partnership’s
leadership; (2) efficiency of the partnership; (3) effective-
ness of the partnership’s administration and manage-
ment; and (4) sufficiency of the partnership’s resources.
This information can help partnerships identify in which
areas they are doing well and in which areas the part-
nership needs to improve the collaborative process [7,8].
We investigated individual assessment of each profes-
sional participating in the disease-management partner-
ships. Analyses could also be performed at the
partnership level taking into account the hierarchical
structure of the data for individuals nested within
partnerships. As there is the potential for considerable
variation within partnerships and since the main pur-
pose of our study was to compare the psychometric
properties of the PSAT in disease-management partner-
ships, we performed confirmatory factor analyses on the
individual level. Ignoring the hierarchical structure of
the data may lead to a worse fit of the model. The factor
loadings found with the two methods (individual versus
team level) will however be similar in value [25,26].
The cumbersome length of the PSAT led us to
perform an item reduction analysis and develop a short
version (PSAT-S), which we later showed was reliable
and valid. The results of the confirmatory factor ana-
lyses revealed good indices of fit with the PSAT-S. As
indicated by the high reliability coefficient, the scale
showed good internal consistency. In case the original
PSAT is considered too lengthy, the PSAT-S is thus a
good alternative. We found support for convergent
validity of the original PSAT and PSAT-S through high
correlations between the partnership dimensions, part-
nership synergy and chronic illness care.
Several psychometric properties could not be evalu-
ated in this study and thus remain undefined, such as
its predictive value. The instrument’s sensitivity to
change requires further investigation. As does its sensi-
tivity to identify changes in the domains of partnership
functioning and synergy for different partnerships. We
also recommend testing the English version of the
PSAT-S in other countries to ensure international valid-
ity. In addition to further research on the predictive
value of the PSAT and PSAT-S, the presence of a
control group (or control sites) would have also
strengthened our conclusions. While it is possible that
completing the PSAT or PSAT-S could act as an inter-
vention based on the incidental education awarded by
the survey itself, we do not think it likely given the diffi-
culty in producing partnership synergy. Response rates
Table 3 Model fit of the full and short models
On imputed data (n = 218) Χ2 (p) RMSEA IFI SRMR
Model 1: 29 items on imputed
data
1627.616 (0.0) 0.0524 0.988 0.0662
Model 2: final short version 15
items
432.634 (0.0) 0.0608 0.988 0.0638
Listwise deletion 29 items
(n = 68)
Model 1: 29 items 97.977 (0.0) 0.0603 0.949 0.0436
Model 2: final short version 170.213 (0.0) 0.0499 0.992 0.0761
Listwise deletion 15 items
(n = 111)
Model 2: final short version 300.730 (0.0) 0.0561 0.990 0.0719
Notes; model 1 = Confirmatory Factor Analysis on full version with 29 items;
Model 2 = Confirmatory Factor Analysis on short version with 15 items
Table 4 Scale characteristics and inter-correlations of the shortened subscales (n = 218)
Items short
version
Cronbach’s
alpha
original full
scale
scale mean
(sd)
inter-item correlations
range
1 2 3
1. Leadership 1, 2, 3, 11 .87 .92** 2.79 (.67) .56-.73
2. Efficiency 12, 13, 14 .75 1.00** 2.60 (.67) .44-.53 .47**
3. Administration and
Management
15, 17, 22, 23 .83 .91** 2.56 (.61) .50-.60 .63** .51**
4. Non financial resources 24, 25, 26, 29 .84 .96** 2.29 (.52) .50-.62 .51** .52** .55**
** p < 0.01 (1-tailed)
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varied widely (35% to 100%). We do not know how the
results might have varied with a better response. Finally,
we did not include patients as partners. Future research
is necessary to investigate patients’ perspectives of part-
nership functioning and use of the PSAT or PSAT-S
among patients as well as professionals.
Conclusions
With these shortcomings in mind, we conclude that the
psychometric properties of the PSAT and the PSAT-S
are good and the PSAT-S is a promising alternate
instrument to evaluate partnership synergy and its
dimensions.
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